Published in
American Association for the Advancement of Science, Science Translational Medicine, 584(13), 2021
DOI: 10.1126/scitranslmed.abb3945
Links
Tools
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
Journal article published in 2021 by
Priya Kumthekar 
,
Caroline H. Ko ,
Tatjana Paunesku ,
Karan Dixit ,
Adam M. Sonabend ,
Orin Bloch,
Matthew Tate,
Margaret Schwartz,
Laura Zuckerman,
Ray Lezon,
Rimas V. Lukas,
Borko Jovanovic,
Kathleen McCortney ,
Howard Colman ,
Si Chen
and other authors.
,
Caroline H. Ko ,
Tatjana Paunesku ,
Karan Dixit ,
Adam M. Sonabend ,
Orin Bloch,
Matthew Tate,
Margaret Schwartz,
Laura Zuckerman,
Ray Lezon,
Rimas V. Lukas,
Borko Jovanovic,
Kathleen McCortney ,
Howard Colman ,
Si Chen
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
RNA interference–based spherical nucleic acid nanoconjugates are a potentially safe and brain-penetrant approach for glioblastoma treatment.